These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35111661)

  • 21. Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma.
    Wang D; Liu S; Wang G
    Front Genet; 2021; 12():709666. PubMed ID: 34552618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma.
    Li W; Ling L; Xiang L; Ding P; Yue W
    Front Cell Neurosci; 2023; 17():1146686. PubMed ID: 36925967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel, effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas.
    Wang B; Tian P; Sun Q; Zhang H; Han L; Zhu B
    Heliyon; 2023 Jul; 9(7):e18075. PubMed ID: 37483735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
    Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
    Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structuring and validating a prognostic model for low-grade gliomas based on the genes for plasma membrane tension.
    Li J; Lv F; Jin T
    Front Neurol; 2022; 13():1024869. PubMed ID: 36408514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer.
    Chen G; Long J; Zhu R; Yang G; Qiu J; Zhao F; Liu Y; Tao J; Zhang T; Zhao Y
    Front Cell Dev Biol; 2021; 9():709669. PubMed ID: 35087823
    [No Abstract]   [Full Text] [Related]  

  • 27. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
    Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
    Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the Role and Clinical Prognostic Value of Target Genes of m6A RNA Methylation Regulators in Glioma.
    Cong P; Wu T; Huang X; Liang H; Gao X; Tian L; Li W; Chen A; Wan H; He M; Dai D; Li Z; Xiong L
    Front Cell Dev Biol; 2021; 9():709022. PubMed ID: 34589481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Nomogram for Predicting Individual Prognosis of Patients with Low-Grade Glioma.
    Zhao YY; Chen SH; Hao Z; Zhu HX; Xing ZL; Li MH
    World Neurosurg; 2019 Oct; 130():e605-e612. PubMed ID: 31319188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
    Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
    Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients.
    Tu Z; Wu L; Wang P; Hu Q; Tao C; Li K; Huang K; Zhu X
    Front Cell Dev Biol; 2020; 8():642. PubMed ID: 32793593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma.
    Deng X; Lin D; Chen B; Zhang X; Xu X; Yang Z; Shen X; Yang L; Lu X; Sheng H; Yin B; Zhang N; Lin J
    Front Oncol; 2019; 9():1310. PubMed ID: 31824866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
    Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
    Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic model and nomogram construction based on autophagy signatures in lower grade glioma.
    Wang C; Qiu J; Chen S; Li Y; Hu H; Cai Y; Hou L
    J Cell Physiol; 2021 Jan; 236(1):235-248. PubMed ID: 32519365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
    Lei K; Li J; Tu Z; Liu F; Ye M; Wu M; Zhu Y; Luo M; Lin L; Tao C; Huang K; Zhu X
    Front Oncol; 2021; 11():665870. PubMed ID: 34123829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of an autophagy-related 10-lncRNA-mRNA signature for distinguishing glioblastoma multiforme from lower‑grade glioma and prognosis prediction.
    Wei B; Wang L; Zhao J
    Gen Physiol Biophys; 2021 Jul; 40(4):257-274. PubMed ID: 34350832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
    Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X
    Front Oncol; 2020; 10():578809. PubMed ID: 33330055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.